YMC Process Technologies Revenue and Competitors

With deep expertise in bio/pharmaceutical systems and chromatography YMC Process Technologies Bio/Pharma Systems' Group engineers deliver standard and custom GMP scale systems noted for unmatched productivity gains, reproducibility, flexibility and efficiency. YMC Corporation acquired the LEWA Bioprocess Group in December 2018, and ChromaCon AG (2019)- our partners in continuous chromatography since 2014. This is a strategic growth opportunity for YMC Corporation who have over 500 employees with facilities in all major geographies and a 40+ year history. We supply systems which meet all the requirements relevant to the industry (BPE, cGMP, GAMP, 21 CFR, etc.) under ISO 9001:2015 QMS. YMC has extensive experience designing, automating and building downstream operations such as: *Chromatography; continuous and batch LPLC & HPLC * Buffer in-line dilution (BID) * Caustic dilution, formulation and in-line blending systems * Biosynthesis (custom) systems * MF & UF/DF (TFF) filtration * OEM Design, Automate & Manufacture Now with ChromaCon AG as part of the YMC Group of companies we combine bring the most advanced yet simple multi-column chromatography systems. We license technology for the production of simulated moving bed (SMB) systems. We are aligned with field services experts like ATG to provide exception, global field support. Our experience is drawn from broad and diverse backgrounds. With this diverse group’s knowledge and its understanding of long-term project goals, YMC is able to simplify communications with clients because it is able to integrate these services together to be a single source.